Richard Aldrich is the co-founder and partner of Longwood Fund. See portfolio, sector focus and contact routes.
Richard Aldrich is the co-founder and partner of Longwood Fund, an early-stage life science venture capital firm based in Boston, Massachusetts, with over 30 years of experience in the biotechnology sector. His investment thesis focuses exclusively on early-stage life science companies, particularly in biotechnology and pharmaceuticals, with a geographic concentration in the United States. Aldrich has served as the lead partner on 21 deals, indicating a strong tendency to lead investments rather than follow. Notable portfolio companies he has co-founded or helped build include Vertex Pharmaceuticals, Sirtris Pharmaceuticals, and Concert Pharmaceuticals, all significant biotech firms. While specific check sizes are not publicly disclosed, Longwood Fund raised an inaugural $85 million healthcare fund in 2010, suggesting substantial early-stage commitments. Aldrich is also a founder of multiple other biotech companies, including Flex Pharma, OvaScience, and Verastem, reflecting a distinctive point of view centered on building and scaling life science enterprises from inception. He has appeared in public discussions on biotech and drug pricing, such as in
Details on this investor come from filing and round data held in the StartupFundraising directory, refreshed on ingest. Founders use profiles like this one to qualify fit and to shortlist investors in Boston.
Investors like Richard Aldrich · Full investor directory · Investor access · Company funding database